Navigation Links
Expert Cardiologist Joins Quintiles Medical Group
Date:10/26/2007

Strengthens support of clinical research protocol development, ECG services

RESEARCH TRIANGLE PARK, N.C., Oct. 26 /PRNewswire/ -- Quintiles Transnational Corp. today announced that Christopher H. Cabell, M.D., MHS, FACC, an expert cardiologist and clinical investigator, has joined the Medical & Scientific Services group in Global Clinical Development Services (CDS). In addition to his CDS work, he provides U.S.-based cardiology expertise for Quintiles ECG Services.

Cabell comes to Quintiles from the Duke University School of Medicine, where he developed a strong background in cardiac safety. He held several appointments within the Duke Clinical Research Institute (DCRI), including Co- Chair and Principal Investigator for a Duke/FDA Cardiac Safety partnership to develop a new generation of tools to identify the potential effects of medical devices and drugs on the heart. Also within DCRI, he held appointments as Director of the Echocardiography Core Laboratory, Associate Director of the ECG Core Laboratory and Director of the International Collaboration on Endocarditis. He also was Assistant Professor of Medicine in the Division of Cardiology.

"As a cardiac safety expert and experienced clinical investigator, Chris will be an important contributor to our customers' efforts to bring safer and more effective medicines to the public," said David Frakes, M.D., Global Vice President, Medical & Scientific Services. "It is essential to identify the potential effects of drugs on the cardiovascular system as early as possible in clinical research. Chris is a significant addition to the expertise of our Medical and Scientific Services team."

Ferzaan Engineer, CEO of Quintiles India and head of Quintiles Technologies (India), said Cabell's support of ECG Services would be of particular interest to U.S.-based customers who rely on Quintiles for round- the-clock analysis of electrocardiograms. "His work at the ECG Laboratory at Duke along with his clin
'/>"/>

SOURCE Quintiles Transnational Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. 2100 expert software Powerful software for the analysis of RNA, DNA, proteins, and cells with the Agilent 2100 bioanalyzer
2. Tired of the spin? ExpertVoter website makes candidate selection easier
3. Innovation expert speaks on the business-IT balancing act
4. Brady appoints GE efficiency expert as CTO
5. Innovation expert says Milwaukee has all the tools
6. Microsoft rewards Berbee for project management expertise
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. RFID expert says piecemeal approach wont work
9. Experts spar over incentives for health-care providers
10. More than ideas needed to make profits, experts say
11. Hacking tools are simple and widely available, security experts say

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...
(Date:12/3/2009)..., Dec. 3 Shire plc (LSE:...armaceutical company, today announced a voluntary ...l of one lot of the Attention-Deficit/Hyperactivit... taking this action because some Daytrana patches ...lease liner removal specification, and as a result...
(Date:12/3/2009)...s., Dec. 3 Inverness Med...ader in enabling individuals to take charge of the...nostics and health management, has declared a divi...e Perpetual Preferred Stock ( IMA-PB). The dividen...mount per share equal to the quotient of (a) $3.00...
(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...LE, Md., Sept. 4 Human Genome,Sciences, Inc. (Nas... at the,BioCentury - Thomson Financial 14th Annive...e will be webcast and may be accessed at, http://w...-bin/prnh/20010612/HGSLOGO ) A member of Human G...t,an overview of the company on Thursday, Septembe...
...STER, Colo., Sept. 4 Allos,Therapeutics, Inc. (Na... on,the development and commercialization of small..., today announced that Paul L. Berns, President an...ar Stearns 20th Annual,Healthcare Conference in Ne...e at 9:00 a.m. (Eastern) on,Monday, September 10, ...
...reas Krause to Present on Statistical Consideratio...to Present on Modeling and Simulation ...lif., Sept. 4 Pharsight,Corporation (OTC Bulletin...strategic services for optimizing clinical drug de...cientists will deliver two presentations,to biopha...
Other Biology Technology:Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3
(Date:12/3/2009)...QUE, N.M. Most scientists believe that staph infe...nal each other to emit toxins. The signaling proce...must be present to start the process. , But the ...e very first stage of staph infection, when bacter...rs in a single cell and that this individual proce...
(Date:12/3/2009)... fish can undergo a personality change in warmer w...ing that climate change may make some species more...oung damselfish on Australia,s Great Barrier Reef ...are either consistently timid, or consistently bol...more marked as water temperatures rise. , A slig...
(Date:12/3/2009)...llers must be included in the design of the upcomi...umanitarian crisis, according to a scientist at th...re , Dr Simon Lewis argues that at least 50% of th...n, known as REDD (Reducing Emissions from Deforest...wellers directly, and their property rights assure...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 1Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 2Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 3Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 4Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 5Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 1Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 2High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 1High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 2
... May 1, 2009 -- With each passing year, the human ... growth has created a wide ranging strain on our w...t, creating an unprecedented urgency to address th...are working towards this goal is through the genet...oving crop yields as well as enhancing the nutriti...
.... (May 4, 2009) The American Society for Neural ...l Meeting April 30 May 2 in Clearwater Beach, Flo...l Award for Brain Repair to Howard J. Federoff, MD...s and Executive Dean of the School of Medicine at ...rnard Sanberg, father of Dr. Paul Sanberg, (Univer...
...Harbor, NY During infancy, each of us emerges fro...llables and learns to speak normally, in the lang...ould happen if we were somehow raised in utter iso... also from surrogates such as nurses and nannies. ...isolation? Would we learn to speak? Would such a l...
Other Biology News:Food security: It starts with seed 2Georgetown University's Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award 2Songbird study from CSHL, CCNY provides concrete measure of biology's impact on culture 2Songbird study from CSHL, CCNY provides concrete measure of biology's impact on culture 3Songbird study from CSHL, CCNY provides concrete measure of biology's impact on culture 4
NucBuster Protein Extraction Kit from Novagen
Goat IgG, Unconjugated from CHEMICON
DETACHaBEAD Mouse CD4 from Dynal Biotech
Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Biology Products: